title: Relation between bronchial responsiveness to inhaled leukotriene D4 and markers of leukotriene biosynthesis.
abstract: BACKGROUND
  While clinical trials with antileukotrienes have shown overall beneficial effects in asthma, the factors that determine leukotriene dependent asthma are still unclear. A study was undertaken to determine whether or not leukotriene responsiveness in the airways correlates with endogenous leukotriene biosynthesis.
  
  
  METHODS
  Bronchial responsiveness to leukotriene (LT) D4 was assessed as PD20FEV1 in 20 subjects with mild asthma and 10 healthy controls, and compared with bronchial responsiveness to methacholine and two global measures of leukotriene production-urinary LTE4 and ex vivo production of LTB4 in whole blood.
  
  
  RESULTS
  In patients with asthma the bronchoconstrictor activity of LTD4 was about 1300 times greater than methacholine (geometric mean PD20 0.69 nmol v 887 nmol). Those who were most responsive to LTD4 were relatively less responsive to methacholine (p<0.01). There was, however, no correlation between bronchial responsiveness to LTD4 and urinary LTE4 or blood ex vivo LTB4 levels in asthmatic subjects or healthy controls. Subjects with asthma treated with inhaled corticosteroids produced higher levels of LTB4 (p<0.05).
  
  
  CONCLUSIONS
  General measures of leukotriene production cannot predict bronchial responsiveness to LTD4. The unique bronchoconstrictive potency of LTD4 on human airways may relate to the locally regulated expression of the cysteinyl LT1 receptor.
authors.affiliation: Division of Respiratory Medicine, Department of Medicine at Karolinska University Hospital Solna, Cenyre for Allergy Research at Karolinska Instituet, Stockholm, Sweden.
authors.forename: P
authors.initials: P
authors.lastname: Gyllfors
authors.forename: M
authors.initials: M
authors.lastname: Kumlin
authors.forename: S-E
authors.initials: SE
authors.lastname: Dahlén
authors.forename: F
authors.initials: F
authors.lastname: Gaber
authors.forename: P-O
authors.initials: PO
authors.lastname: Ehrs
authors.forename: B
authors.initials: B
authors.lastname: Dahlén
mesh_terms: D000328:Adult; D001249:Asthma / Q000503:physiopathology*; D015415:Biomarkers / Q000378:metabolism; D001980:Bronchi / Q000187:drug effects*; D016085:Bronchoconstrictor Agents / Q000494:pharmacology; D003430:Cross-Sectional Studies; D004305:Dose-Response Relationship, Drug; D005260:Female; D005541:Forced Expiratory Volume / Q000502:physiology; D006801:Humans; D007476:Ionophores / Q000378:metabolism; D017998:Leukotriene D4 / Q000008:administration & dosage / Q000494:pharmacology* / Q000652:urine; D015289:Leukotrienes / Q000096:biosynthesis*; D008297:Male; D016210:Methacholine Chloride / Q000494:pharmacology
chemical_list: D015415:Biomarkers; D016085:Bronchoconstrictor Agents; D007476:Ionophores; D015289:Leukotrienes; D016210:Methacholine Chloride; D017998:Leukotriene D4